Maria B.
- Country
- Sweden
- Department
- VO hematologi, onkologi och strålningsfysik
Research Overview
- Phase 3 Randomized Open-Label Trial of Tisotumab Vedotin Versus Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
- Continuation Study of Olaparib in Patients with BRCA-Mutated Ovarian, Metastatic Breast, Pancreatic, Prostate, and Endometrial Cancers
Data & Insights
Has run more than one trial at 77 of 174 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in treating various forms of cervical cancer, with particular emphasis on advanced disease states including recurrent and metastatic cervical carcinoma.
- Advanced Cervical Cancer Management
- Second and Third-line Treatment Approaches
- Metastatic Disease Interventions
Their expertise extends to novel therapeutic combinations for cervical cancer treatment.
Hereditary Cancer Syndromes
The investigator focuses on BRCA-mutated cancers across multiple organ systems, including therapeutic approaches for patients with genetic predispositions to cancer.
- BRCA-Mutated Ovarian Cancer
- Hereditary Breast Cancer
- Genetic Mutation-Based Treatments
Their work encompasses targeted therapies for genetically-driven malignancies.
Multi-System Oncology
This investigator has expertise in treating diverse cancer types including pancreatic cancer, prostate cancer, and endometrial cancer.
- Epithelial Ovarian Cancer
- Metastatic Pancreatic Cancer
- Advanced Prostate Cancer
Their therapeutic approach spans multiple organ systems and cancer types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.